Get the Weekly Intelligence Brief — top committee picks every Sunday.
JBS · NYSE · STOCK

Jbs (JBS) Stock Analysis

Consumer Defensive Updated October 10, 2026
$12.97
52W $10.61 – $18.65
49/100
$28.79B
17.3
0.16
AI Committee Verdict
Watch
49/100
Conviction: Contested · 50% agreement · 6 analysts
+10.6%
-0.8%
13.04:1
Contested

Is JBS Bullish or Bearish?

Mixed. Innellis AI committee rates Jbs N.V. (JBS) Watch with a composite score of 49/100 , based on 6 analysts with 50% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +10.83 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -9.17 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case. Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • P/E of 12.5 is inexpensive for the broad market — Value
  • MACD histogram positive -- bullish momentum — Technical
Bear Case
  • Debt-to-equity of 2.65 adds balance-sheet risk to the value case — Value
  • EPS declining -47.9% YoY despite any revenue growth — Growth
  • 2 consecutive earnings misses -- execution concerns — Growth
  • RSI at 75 is in overbought territory — Technical
  • Price trading above the upper Bollinger Band -- stretched — Technical
  • High leverage (debt-to-equity 2.65) amplifies downside in a stress scenario — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
49/100
Agreement
50%
Analysts
6
Conviction
Contested
Sector Rank
Top 90%
of 72 Consumer Defensive peers
Value Analyst neutral
57 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ P/E of 12.5 is inexpensive for the broad market
− Debt-to-equity of 2.65 adds balance-sheet risk to the value case
Growth Analyst bearish
35 / 100 · High confidence
Growth story is weak, decelerating, or inconsistent
− EPS declining -47.9% YoY despite any revenue growth
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
− RSI at 75 is in overbought territory
Risk Analyst bearish
32 / 100 · Moderate confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− High leverage (debt-to-equity 2.65) amplifies downside in a stress scenario
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst neutral
58 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 49.0 to 49.2.

Analyst-level changes:
  • Risk Analyst: +1 bearish signal(s).
  • Technical Analyst: +2 bearish signal(s).
  • Value Analyst: +1 bullish signal(s).

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
74.9
Overbought
MACD Histogram
0.203
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$12.87
Resistance
$14.35
Bollinger %B
1.02
Above Upper Band
Price vs Moving Averages
EMA 9
$12.19 Above
EMA 21
$12.16 Above
EMA 50
$12.51 Above
EMA 200
$13.60 Below

Fundamental Analysis

Valuation
64
Growth
25
Profitability
38
Financial Health
31
Cash Flow
70
Valuation
P/E Ratio 17.3×
P/B Ratio 8.04×
PEG Ratio -0.54
Dividend Yield 7.70%
52W High $18.65
52W Low $10.61
Quality & Growth
ROE 2318.3%
ROA 446.8%
Gross Margin 1185.7%
Operating Margin 384.4%
Revenue Growth YoY —
Debt / Equity 2.97
AI Fundamental Assessment
P/E ratio of 17.3 (inexpensive relative to a 15-40x range); Price-to-book of 8.0x; PEG ratio of -0.5 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 23.2%; Return on assets of 4.5%; Net margin of 1.7%; Gross margin of 11.9%; Current ratio of 1.53 (healthy short-term liquidity); Debt-to-equity of 2.97; Free cash flow per share is positive (2.09); Most recent quarter missed estimates by 68.7%; 2 consecutive earnings misses; EPS growth roughly steady (-51.2% -> -50.0% QoQ); Analyst estimates falling over recent quarters
Get the Full JBS Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime